Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multi-center, Randomized, Double-blind, Placebo-controlled Dose Modification Study to Evaluate the Safety and Efficacy of Single Oral Doses of Vanoxerine for Conversion of Subjects With Atrial Fibrillation or Flutter of Recent Onset to Normal Sinus Rhythm

Next Previous
X
Search
Trial Profile

Multi-center, Randomized, Double-blind, Placebo-controlled Dose Modification Study to Evaluate the Safety and Efficacy of Single Oral Doses of Vanoxerine for Conversion of Subjects With Atrial Fibrillation or Flutter of Recent Onset to Normal Sinus Rhythm

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 24 Dec 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Vanoxerine (Primary)
  • Indications Atrial fibrillation; Atrial flutter
  • Focus Therapeutic Use
  • Acronyms COR-ART
  • Sponsors ChanRx

    • Most Recent Events

    • 17 Nov 2013 Two of the three planned vanoxerine cohorts have been randomised to 200mg (n=22) 300mg (n=25) and placebo (n=22). The third cohort (400mg) is currently being enrolled according to the abstract preseneted at AHA.
    • 17 Nov 2013 Interim results for the 200 and 300mg cohorts presented at the 86th Annual Scientific Sessions of the American Heart Association.
    • 01 Oct 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top